Works matching IS 0344-5704 AND VI 65 AND IP 2 AND DT 2010
Results: 30
Quantitative structure–property relationships of camptothecins in humans.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Phase I/II study of the lipiodolization using DDP-H (CDDP powder; IA-call((R))) in patients with unresectable hepatocellular carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1[alpha] in tumor and normal cells.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
A phase I study of larotaxel (XRP9881) administered in combination with carboplatin in chemotherapy-naïve patients with stage IIIB or stage IV non-small cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-[alpha]5[beta]1 integrin monoclonal antibody (volociximab) in cancer patients.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 399, doi. 10.1007/s00280-009-1118-2
- By:
- Publication type:
- Article
The contribution of deleterious DPYD gene sequence variants to fluoropyrimidine toxicity in British cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 403, doi. 10.1007/s00280-009-1147-x
- By:
- Publication type:
- Article
Preclinical rationale for combined use of endocrine therapy and 5-fluorouracil but neither doxorubicin nor paclitaxel in the treatment of endocrine-responsive breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 219, doi. 10.1007/s00280-009-1024-7
- By:
- Publication type:
- Article
Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 319, doi. 10.1007/s00280-009-1036-3
- By:
- Publication type:
- Article
Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 277, doi. 10.1007/s00280-009-1032-7
- By:
- Publication type:
- Article
A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- Report
Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent d-19575 (glufosfamide) in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 243, doi. 10.1007/s00280-009-1028-3
- By:
- Publication type:
- Article
Celecoxib prevents tumor growth in an animal model by a COX-2 independent mechanism.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 267, doi. 10.1007/s00280-009-1031-8
- By:
- Publication type:
- Article
Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α<sub>5</sub>β<sub>1</sub> integrin monoclonal antibody (volociximab) in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 207, doi. 10.1007/s00280-009-1023-8
- By:
- Publication type:
- Article
Quantitative structure–property relationships of camptothecins in humans.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 325, doi. 10.1007/s00280-009-1037-2
- By:
- Publication type:
- Article
A phase I study of larotaxel (XRP9881) administered in combination with carboplatin in chemotherapy-naïve patients with stage IIIB or stage IV non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 227, doi. 10.1007/s00280-009-1026-5
- By:
- Publication type:
- Article
Effect of antisense oligomer in controlling c-raf.1 overexpression during diethylnitrosamine-induced hepatocarcinogenesis in rat.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 309, doi. 10.1007/s00280-009-1035-4
- By:
- Publication type:
- Article
A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas.
- Published in:
- 2010
- By:
- Publication type:
- Report
Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 259, doi. 10.1007/s00280-009-1030-9
- By:
- Publication type:
- Article
Phase 1 first-in-human clinical study of S- trans, trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 235, doi. 10.1007/s00280-009-1027-4
- By:
- Publication type:
- Article
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 353, doi. 10.1007/s00280-009-1041-6
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 335, doi. 10.1007/s00280-009-1039-0
- By:
- Publication type:
- Article
Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 251, doi. 10.1007/s00280-009-1029-2
- By:
- Publication type:
- Article
Dual targeting of tumour cells and host endothelial cells by novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 289, doi. 10.1007/s00280-009-1033-6
- By:
- Publication type:
- Article
A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 363, doi. 10.1007/s00280-009-1042-5
- By:
- Publication type:
- Article
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme.
- Published in:
- 2010
- By:
- Publication type:
- Report
The effect of transcatheter arterial chemoembolization on phase II drug metabolism enzymes in patients with hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 347, doi. 10.1007/s00280-009-1040-7
- By:
- Publication type:
- Article
Bexarotene: a promising anticancer agent.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 201, doi. 10.1007/s00280-009-1140-4
- By:
- Publication type:
- Article
Phase I/II study of the lipiodolization using DDP-H (CDDP powder; IA-call<sup>®</sup>) in patients with unresectable hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 301, doi. 10.1007/s00280-009-1034-5
- By:
- Publication type:
- Article